Stephen Klasko, M.D.

Dr. Stephen Klasko, MD is a transformative leader and advocate for a revolution in our systems of healthcare and higher education. His 2018 book is titled, Bless This Mess: A Picture Story of Healthcare in America – an account of how the USA was elected to the Intergalactic Council of Cool Health Systems by 2035.

As President of Philadelphia-based Thomas Jefferson University and CEO of Jefferson Health he has steered since 2013 one of the nation’s fastest growing academic health institutions based on his vision of re-imagining health care and higher education. His 2017 merger of Thomas Jefferson University with Philadelphia University creates a pre-eminent professional university that includes top-20 programs in fashion and design, coupled with the first design thinking curriculum in a medical school, and with the nation’s leading research on empathy.

His track record of success at creating and implementing programs that are shaping the future of health care earned him a place among Fast Company’s 100 Most Creative People in Business in 2018; and Ernst & Young’s Greater Philadelphia Entrepreneur of the Year in 2018. He is also ranked #2 on Modern Healthcare’s list of Most Influential People in Healthcare. For 2018-19 U.S.News & World Report has ranked Thomas Jefferson University Hospital among the nation’s best in 10 specialties, and Magee Rehabilitation Hospital – Jefferson Health 13th Best Hospital in the nation for physical rehabilitation. In 2018, Jefferson was invited to join the World Economic Forum.

Dr. Klasko is a nationally recognized advocate for healthcare transformation, having served as dean of two medical colleges, and leader of three academic health centers before becoming President and CEO at Jefferson. He is author of 1999’s The Phantom Stethoscope, 2016’s We Can Fix Healthcare in America, and editor in chief of the journal “Healthcare Transformation.”

Under his leadership, Jefferson Health has grown from three hospitals to 14 with revenues that grew from $2.2 billion to more than $5.1 billion, annualized. The new Jefferson focuses on managing the health of populations in southeastern Pennsylvania and southern New Jersey. Jefferson has the largest faculty based tele-health network in the country, the NCI-designated Sidney Kimmel Cancer Center, and an outpatient footprint that is among the most technologically advanced in the region.

This rapid growth led in 2017 to GE Healthcare signing with Jefferson Health the largest risk-shared partnership in the U.S., aimed at saving more than $500 million over eight years.

Jefferson has 2018 annualized post-merger revenues of $5.1 billion, more than 30,000 employees, 7,800 students, 6,600 physicians/practitioners and 4,400 faculty.

Through a unique four pillar model, academic-clinical-innovation-philanthropy, Jefferson has attracted both venture capital and transformational gifts. Sidney and Caroline Kimmel donated $110 million to Jefferson on June 18, 2014, the largest gift in the University’s history. Philanthropy and innovation have also resulted in the addition of the Marcus Institute of Integrative Health, nationally recognized for its modern medical and integrated therapies, and the Jane and Leonard Korman Respiratory Institute, a unique partnership between Jefferson Health and National Jewish Health.

Previously, as CEO of USF Health and Dean of the Morsani College of Medicine at the University of South Florida, Dr. Klasko built the nation’s largest “assessment of technical and teamwork competence” center known as CAMLS (Center for Advanced Medical Learning and Simulation). He also led a partnership with the country’s largest retirement community, The Villages, to create “America’s healthiest hometown,” an innovative primary-care-driven, patient-centric, Medicare-based accountable care model.

Dr. Klasko is ideally suited to lead such initiatives, having completed a grant after receiving his MBA from the Wharton School of Business of the University of Pennsylvania on selecting and educating physicians to be leaders of change. His unique medical education program at USF, called SELECT (Scholarly Excellence, Leadership Education, Collaborative Training), is recognized for its focus on choosing medical students based on emotional intelligence and leadership potential.

Dr. Klasko also serves on the board of Teleflex (TFX), a NYSE global medical device company with a market cap of $12 billion. He has served on both the audit committee and governance committee and has been a director since 2008. He also is a trustee of Lehigh University, one of the nation’s leading engineering and business schools.

He is married to Colleen Wyse, a fashion leader and founder of The Philadelphia Trunk Show, and has three children: Lynne, David and Jill.

Martha Rebour

Martha Rebour joined the UN Foundation in 2014. She serves as Senior Director of Shot@Life, a global campaign to increase access to immunizations for children in need through UN partners. She oversees its marketing, communications, corporate partnerships, and brand strategy. Martha has more than 15 years of experience in strategic branding,social media marketing, creative development and consumer research for corporate and nonprofit organizations. Prior to joining the UN Foundation she worked for 10 years at Discovery Communications and oversaw marketing campaigns such as the 20th Anniversary of Shark Week, the BBC series LIFE and Mythbusters, and subsequently ran her own marketing firm where she directed strategic planning and marketing for clients such as the InterAmerican Development Bank, Ogilvy Public Relations, National Geographic, and PBS. She holds a B.A. from Colby College and an MA in French language from New York University.

David Nikodem, Ph.D.

Dr. Nikodem has over 15 years of investment experience as an investor with a global investment focus across all healthcare subsectors. He currently manages the BioPharmaceutical team at Ally Bridge Group, a Hong Kong based investment fund focused on Healthcare. Previously, David had been responsible for portfolio construction, risk management and all portfolio decisions for Exane Asset Management’s Equinox Fund in Paris, as well as on BNP Paribas’ proprietary desk in New York. Prior to healthcare investing, David worked as a patent examiner at the United States Patent & Trademark Office and as a basic science researcher at the National Institutes of Health. Dr. Nikodem holds a Ph.D. in Biochemistry and Molecular Biology from Georgetown University and a BA in Chemistry from The University of Virginia.

Carole Wainaina

A citizen of Kenya, Ms. Wainaina is a well-respected senior executive with global experience in the private and public sectors at senior levels, including strategy formulation, leading multi-disciplinary teams, and driving organizational change.

Before joining Africa50, she served as the Assistant Secretary General for Human Resources of the United Nations, leading transformational initiatives for the Secretary General and member states. Prior to joining the United Nations in 2014, Ms. Wainaina held senior positions for more than two decades at multinational corporations in Turkey, the United States, the United Kingdom, the Netherlands, and Kenya. She served for three years on the Executive Committee of Royal Philips in the Netherlands as Executive Vice President and Chief Human Resources Officer. Prior to this, she worked for 13 years at Coca-Cola in senior roles, including Chief of Staff of the Chairman and CEO, Group HR Director Eurasia and Africa, and President of the Coca-Cola Africa Foundation. She started her career at Price Waterhouse Coopers in Kenya. She holds a Bachelor of Business Administration Degree from the University of Southern Queensland in Australia.

Eriko Ishikawa

Eriko is the Global Program Manager and a founding member of the Inclusive Business Models Group. For the past few years, Eriko has worked on a corporate-wide strategy to better integrate IFC’s advisory and investment functions to help private sector companies reach populations at the Base of the Pyramid (BOP).

Eriko has led teams to provide technical assistance and advisory services to IFC corporate clients to strengthen their local supply chain and provide access to finance in emerging markets (Peru, Brazil, India, Mozambique). She has also worked with companies in emerging markets to capture their operational impact on the BOP and has co-authored several publications on this topic. She has been the project manager for a series of private sector BOP roundtables organized by IFC and the Harvard Kennedy School – the Rio Roundtable (2008) and the Jaipur Roundtable in (2009) – and the multi-stakeholder event on Inclusive Business Solutions in DC (2010).

Eriko has also worked for the Southern Europe Central Asia region, at IFC on real sector as well as financial sector projects: agribusiness, global manufacturing, SME credit lines and microfinance investments in Central Asia (Kazakhstan, Uzbekistan, and the Kyrgyz Republic).

Prior to joining IFC, she was a Vice President for international corporate finance at Citibank in New York, covering Latin American and Japanese clients. She was born in Japan, grew up in Brazil, and has been educated in the US. She holds an M.B.A. degree from the Stanford Graduate School of Business and an A.B. and M. Ed. degrees from Harvard University. When she is not trekking through the rainforest in Brazil, the tribal communities in India, or Mozambican back roads for work, her main hobby is scuba diving – the Red Sea, Micronesia, South Pacific, Okinawa and the Caribbean are her favorite spots so far.

Ari Eisentat

At 29 years old, Ari Eisenstat is the Co-Executive Director of the UN Global Sustainability Index Institute, an independent foundation mandated to measure and accelerate capital for the 2030 Sustainable Development Goals. Through education, investment, and a comprehensive index, UNGSII empowers stakeholders from all sectors to achieve the global goals. (UNGSII.org)

Ari is also the CEO and Founder of DREAM VENTURES GLOBAL, an idea-stage impact venture fund with the mission of funding the next generation of socially, environmentally, and technologically conscious entrepreneurs.

Ari was selected to be an International Chamber of Commerce representative to the United Nations during the post-2015 negotiations, and is a member of the UN’s Interagency Working Group for Youth and Gender Equality. He is the cofounder of the “U.N.trepreneurship Initiative,” which connects entrepreneurs and intrapreneurs across sectors to innovate for the 2030 Global Goals for Sustainable Development.  Ari regularly delivers the DRÆMATHON Social Venture Creation Workshop to students to some of the world’s leading universities, including Stanford, Harvard, UC Berkeley, MIT and NYU. In addition, he  mentors startups with top incubator and accelerator programs.

Katherine St. Onge

Katherine St. Onge is a Senior Officer on the Investor Relations team. She is responsible for managing relationships with individual investors, foundations, institutions and financial advisors to increase the ir understanding of Calvert Foundation’s impact investing product and services. Prior to Calvert Foundation, Katherine worked at the Aspen Institute where she focused on building entrepreneurial and early-stage investment ecosystems in the Middle East and North Africa. She also worked for Louisiana Economic Development, crafting policies and strategies to enhance the state’s economic competitiveness, and Goldman Sachs, managing both equity and fixed-income investment products. She received her Bachelor’s Degree in economics and mathematics from Bucknell University and her M.B.A. from the Wharton School at the University of Pennsylvania.

Greg Simon

Greg Simon serves as Director of the Biden Cancer Initiative at the Biden Foundation. Previously, he was the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama and for which he was chosen by Vice President Joe Biden in March 2016. As Executive Director, Greg assembled and led a team of eight professionals to support the work of the Vice President in developing and promoting the goals of the Cancer Moonshot in numerous meetings and presentations and to coordinate the work of the Task Force comprised of twenty cabinet and sub-cabinet offices.

Over the past ten months Greg and his team worked across the Task Force, academia and the private sector to create over seventy innovative collaborations. On October 17th, 2016, Greg joined the Vice President to present the Cancer Moonshot reports to President Obama in an Oval Office briefing. On December 7, 2016, the passage of the 21st Century Cures Act provided $1.8 billion for the Cancer Moonshot over the next seven years.

In his career, Greg has held senior positions in both chambers of Congress, was Chief Domestic Policy Advisor to Vice President Al Gore, was a senior strategy consultant to a variety of international technology CEO’s, co-founded and led FasterCures and the Melanoma Research Alliance, was the Senior Vice President at Pfizer for worldwide policy and public engagement and was the CEO of Poliwogg, a financial services company creating unique capital market opportunities in healthcare and life sciences. He has developed a reputation as a visionary strategist, a dynamic public speaker and writer, and as a knowledgeable analyst of emerging trends in healthcare, information technology, innovative drug research and development and patient advocacy.

Greg came to Washington, DC in 1985 as General Counsel and then Staff Director of the Investigations Subcommittee of the House of Representatives’ Science, Space and Technology Committee. During his years with the Science Committee, Greg organized a series of investigatory hearings on biotechnology policy and was involved in hearings and investigations related to NASA and the Challenger explosion, scientific misconduct, the use of human biological materials in research and the artificial heart program.   

Mr. Simon served as Sen. Gore`s Legislative Director from 1991 to 1993 before joining him in the White House as his Chief Domestic Policy Advisor. He was the lead staffer for the Clinton-Gore Administration for development and passage of the Telecommunications Reform Act of 1996 as well as development of the National and Global Information Infrastructure. He represented the Vice President on the National Economic Council, helped negotiate the US-Russia agreement on the International Space Station and oversaw a number of key initiatives, including programs at the National Institutes of Health, the National Cancer Institute, the Food and Drug Administration, and the Human Genome Project. He was also instrumental in crafting the regulatory framework that is now the foundation for the biotechnology industry.

Following his White House service Greg was CEO of Simon Strategies and provided strategic advice to CEO’s of major firms such as Sony, Cisco, Netscape, Motorola, Sega and AOL.

Starting in 2003, Mr. Simon worked with Mike Milken to co-found FasterCures/The Center for Accelerating Medical Solutions. FasterCures has become an organization valued and recognized for catalyzing systematic change in the process of discovery and development and of new therapies for deadly and debilitating diseases. 

Under Greg’s leadership, FasterCures created the FasterCures Philanthropy Advisory Service, with funding from the Robert Wood Johnson Foundation and the Bill & Melinda Gates Foundation.  This initiative accelerates and increases the flow of philanthropic support to nonprofit medical research organizations by providing in-depth data on the methods, goals, and potential impacts of nonprofit medical research organizations engaged in specific disease areas. He also created The Research Acceleration and Innovation Network (TRAIN) to promote innovation in disease research and to support the activities of organizations engaged in cutting-edge research.

While at FasterCures Greg co-founded the Melanoma Research Alliance with Leon and Debra Black.

From 2009-1012 Simon was Senior Vice President for Worldwide Policy and Patient Engagement at Pfizer, Inc. He led a global team of professionals in:  1) worldwide government policy, 2) science policy, 3) economic policy and research, and 4) international policy. He advised the CEO on the company’s efforts in Healthcare Reform.  He also focused on engaging patients more productively in research and clinical trials and on helping Pfizer develop policies, practices, and medical solutions to improve health, happiness and productivity.

Prior to becoming Executive Director of the Cancer Moonshot, Greg was the CEO of Poliwogg, a financial services company creating unique capital market opportunities in healthcare and life sciences. Poliwogg’s first index, the Poliwogg Medical Breakthroughs Index, was the basis for the best performing health Exchange Traded Fund, “SBIO,” in 2015.

The journal Nature Medicine named Greg one of “Ten People to Watch” in health care policy, noting that he was among “a handful of influential people who quietly keep the wheels of biomedical science turning.” In 2010 he received the Genetic Alliance’s “Art of Advocacy” award. In May 2011 Greg was invited to be the second lecturer in the Constantin Spiegelfeld Lecture series of the Research Center for Molecular Medicine of the Austrian Academy of Sciences. He is the recipient of the Arab American Institute’s 2017 Najeem Halaby Public Service Award established by Queen Noor in memory of her father. He is a regular presenter at the Milken Institute Global Conference, the OECD, the Washington Campus (a nonprofit educational institution in Washington, D.C.) and at health conferences and academic institutions around the country.

He received his law degree from the University of Washington in 1983 where he was a member of the Law Review and the Moot Court. He has a B.A. in history from the University of Arkansas.

Alexis Bonnell

Alexis Bonnell is the Chief of Applied Innovation & Acceleration in the U.S. Global Development Lab, of USAID, one of the premier Innovation Labs in the development industry. She serves as a key spokesperson and “Innovation Evangelist” across the industry driving innovation and modernization. 
Over her career, Bonnell has developed and delivered over a billion dollars of innovative humanitarian and development programming in over 25 conflict, post-conflict and emergency countries, in almost every sector from education to stabilization, for more than 30 international bilateral donors, 10 U.N. agencies, the military and the private sector.

With more than 20 years of experience in management and communications, Bonnell has worked with: Wall Street and “dot.coms,” and on projects such as the Middle East Peace Plan, Afghan and Iraqi elections, tsunami response, Pakistan and Haiti earthquakes, over 500 construction projects, and major logistics operations.

After years of working overseas, Bonnell returned to the United States with USAID as the senior adviser on business transformation and knowledge management. She then served as the Chief of Engagement for the Office of Education, where she helped shape the USAID Education Strategy.

Prior to her career in development, Bonnell worked as director of marketing for the Internet Trade Association, where she helped Wall Street and the corporate world understand the impact that the Internet, innovation and technology would have on business, customers and society. She is co-author of the book “Get your Dream Job.”

Bonnell received a dual major in advertising and public relations from Pepperdine University, where she later returned as a professor. She also received a global executive Master’s Degree in business administration from Kellogg Northwestern and a Master’s Degree in direct and interactive media from New York University.

Mary-Frances Wain

Mary-Frances Wain serves as Executive Director of Philanthropic Investments for the United Nations Foundation. As the organization’s chief engagement officer for individuals and families, Mary-Frances works with philanthropists who wish to have a global impact by supporting the work of the United Nations.  Mary-Frances joined UNF in February 2012 and has more than 20 years of not-for-profit management experience with successful track record of “matchmaking” donors with effective agents of the change they wish to make in the world. Mary-Frances has specific expertise in organizational sustainability and resource development for initiatives focused on at-risk audiences.

Mary-Frances previously served as Vice President of Philanthropy for the Make-A-Wish Foundation® of the Mid-Atlantic. Mary-Frances also headed a nonprofit consulting company specializing in organizational capacity building, with a portfolio including the Choice Hotels International Foundation, the Pentagon Memorial Fund, The Community Foundation for the National Capital Region, the Center for Alexandria’s Children, Cultural Tourism DC, and Higher Achievement.  Mary-Frances also served as executive director of Suited for Change, a Washington, DC based nonprofit that provides professional clothing and coaching to low-income women seeking employment, and as director of corporate relations for the National Museum of Women in the Arts, community relations manager for Neiman Marcus, and education manager for the American Advertising Federation, where she helped to establish the American Advertising Foundation to focus on minority scholarships.

Mary-Frances is an alumnus of Syracuse University’s S.I. Newhouse School of Public Communications and is an active member of the Association of Fundraising Professionals. She regularly speaks at industry conferences and events and serves on advisory committees and boards for several DC-area NGOs. She is an avid runner, plays mandolin banjo, and resides in Washington, DC with her husband, their 10-year old son and his two-year-old labradoodle.